SCHEMBL2213170

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2211424	0.91	GCK (0.57)	GCKRAB9AADORA3KDM4EMEN1
	SCHEMBL2213081	0.86	GCK (0.56)	GCKRAB9AADORA3KDM4EMEN1
	SCHEMBL2211408	0.86	GCK (0.57)	GCKRAB9AMAPTSMN1; SMN2
	SCHEMBL2215647	0.85	GCK (0.57)	GCKRAB9AADORA3KDM4EMEN1
	SCHEMBL2213220	0.85	GCK (0.55)	GCKADORA3MEN1KMT2A
	SCHEMBL2642911	0.84	GCK (0.75)	GCKRAB9ALMNATSHRSMN1; SMN2
	SCHEMBL2212562	0.84	GCK (0.48)	GCKKDM4EMEN1LMNAMAPT
	SCHEMBL2211361	0.83	GCK (0.59)	GCK
	SCHEMBL2210335	0.83	GCK (0.54)	GCKKDM4E
	SCHEMBL2213463	0.83	GCK (0.48)	GCKMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.